Recently Recorded
Newly Opened Phase 3 Study for Low
Grade Serous Ovarian Cancer
Rachel Grisham, MD
Section Head Ovarian Cancer
Director, Gynecologic Medical Oncology
Memorial Sloan Kettering Cancer Center
USA
Susana Banerjee, MBBS, MA, PhD, FRCP
Consultant Medical Oncologist
Research Lead Gynaecology Unit
The Royal Marsden
Professor in Women’s Cancers,
Institute of Cancer Research, London
UK
Dr. Rachel Grisham and Dr. Susana Banerjee discussed details about a potential clinical trial for your patients. The RAMP 301 trial is evaluating the novel combination of avutometinib + defactinib versus investigator’s choice of therapy in patients with recurrent low grade serous ovarian cancer.
Radiation Treatment for Gynecologic Malignancies
and the Vital Role of Nursing
Kayla Kafka-Peterson, RN, BSN
Nursing Supervisor II Radiation Oncology
Brachytherapy Program Operations Oversight
University of California Los Angeles (UCLA)
USA
Puja Venkat, MD
Assistant Clinical Professor, Radiation Oncology
Equity, Diversity and Inclusion Co-Chair
University of California Los Angeles (UCLA)
USA
Radiation therapy plays a critical role in the treatment of many types of gynecologic cancer. This webinar will explain the rationale behind radiation treatment for gynecologic malignancies, different treatment modalities (including both external beam radiation therapy and brachytherapy), as well as how to care for patients undergoing radiation therapy. Nursing care will be covered in-depth, with a special emphasis on patient education and side effect management. This webinar will focus heavily on external beam radiation therapy. We will have a second part to this webinar that will cover brachytherapy in depth.
Refresher on Selecting Genetic Testing
for Ovarian Cancer Treatment Decisions
Thomas C. Krivak, MD
Director, Division of Gynecologic Oncology
Director, Gynecologic Oncology Research Program
The Western Pennsylvania Hospital
USA
Leigha Senter-Jamieson, MS, CGC
Certified Genetic Counselor
Associate Director of Division of Human Genetics
The Ohio State University
USA
Supported in part by GSK
The Evolving Treatment Landscape for The Management of Endometrial Cancer
IGCS and Eisai welcomes gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other clinicians who treat patients with gynecologic malignancies to view the first presentation from the An Evolving Frontier - Understanding Novel Treatment Options for The Management of Advanced Stage or Recurrent Endometrial Cancers Industry Supported Symposium presented at the IGCS 2023 Annual Global Meeting in Seoul, Korea.
Ramez Eskander, MD
Clinical Professor Department of Obstetrics, Gynecology, and Reproductive Sciences
University of California San Diego
USA
Eisai have sponsored this initiative with IGCS and had no input into or influence over the content.
Visit Education360 Learning Portal for more.